Literature DB >> 25663011

Impact of Combination Criteria of Nodal Counts and Sizes on Preoperative MDCT in Advanced Gastric Cancer.

Tsutomu Kawaguchi1, Daisuke Ichikawa2, Shuhei Komatsu1, Toshiyuki Kosuga1, Takeshi Kubota1, Kazuma Okamoto1, Atsushi Shiozaki1, Hitoshi Fujiwara1, Hirotaka Konishi1, Ryo Morimura1, Yasutoshi Murayama1, Yoshiaki Kuriu1, Hisashi Ikoma1, Masayoshi Nakanishi1, Chouhei Sakakura1, Eigo Otsuji1.   

Abstract

BACKGROUND: This study was designed to establish a new diagnostic criteria of preoperative nodal status with high specificity on multidetector row computed tomography (MDCT) to extract advanced gastric cancer (GC) patients with an unfavorable prognosis.
METHOD: From total of 480 GC patients who underwent surgical resection, 58 consecutive patients with a preoperative diagnosis of nodal metastasis on MDCT were included in this retrospective study. Nodal status on MDCT was reassessed and a prognostic analysis was performed in the present study.
RESULTS: Among several clinical nodal diagnostic criteria on MDCT, a cut-off value of the short-axis diameter measuring ≥15 mm showed the highest specificity (100%). The prognostic analysis revealed that patients with nodal counts on MDCT of ≥3 (p = 0.035) as well as those with a nodal diameter ≥15 mm (p < 0.001) had a significantly poor prognosis. When patients with nodal counts ≥3 and at least one node that was ≥15 mm in diameter on MDCT were defined as having extensive lymph node metastasis (ELM) that had a significantly poor prognosis (5-year survival rates of 20%, p < 0.001), and ELM was also an independent poor prognostic factor in advanced GC (p = 0.033, hazard ratio 4.038).
CONCLUSION: GC patients with nodal counts ≥3 and at least one node that was ≥15 mm in diameter on MDCT have extremely worse prognose with high diagnostic specificity. This novel surrogate indicator for preoperative imaging diagnosis may help personalized therapeutic strategies for GC patients with ELM.

Entities:  

Mesh:

Year:  2016        PMID: 25663011     DOI: 10.1007/s00268-015-3007-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

1.  Prognostic significance of the number of metastatic lymph nodes in patients with gastric cancer.

Authors:  M Makino; S Moriwaki; M Yonekawa; M Oota; O Kimura; N Kaibara
Journal:  J Surg Oncol       Date:  1991-05       Impact factor: 3.454

2.  Clinical evaluation of JCGC and TNM staging on multidetector-row computed tomography in preoperative nodal staging of gastric cancer.

Authors:  Tsutomu Kawaguchi; Daisuke Ichikawa; Shuhei Komatsu; Kazuma Okamoto; Yasutoshi Murayama; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Hitoshi Fujiwara; Toshiya Ochiai; Yukihito Kokuba; Teruhisa Sonoyama; Tsunehiko Nishimura; Eigo Otsuji
Journal:  Hepatogastroenterology       Date:  2011 May-Jun

Review 3.  Imaging in assessing lymph node status in gastric cancer.

Authors:  Robert Michael Kwee; Thomas Christian Kwee
Journal:  Gastric Cancer       Date:  2009-04-24       Impact factor: 7.370

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Prognostic significance of the number of positive lymph nodes in gastric carcinoma.

Authors:  Y Adachi; T Kamakura; M Mori; H Baba; Y Maehara; K Sugimachi
Journal:  Br J Surg       Date:  1994-03       Impact factor: 6.939

6.  Lymphadenectomy in gastric carcinoma. A prospective and prognostic study.

Authors:  J Jaehne; H J Meyer; H Maschek; H Geerlings; E Burns; R Pichlmayr
Journal:  Arch Surg       Date:  1992-03

7.  Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.

Authors:  J D Roder; K Böttcher; J R Siewert; R Busch; P Hermanek; H J Meyer
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

8.  The impact of preoperative lymph node size on long-term outcome following curative gastrectomy for gastric cancer.

Authors:  Masanori Tokunaga; Norihiko Sugisawa; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  Ann Surg Oncol       Date:  2012-11-02       Impact factor: 5.344

9.  Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.

Authors:  A Tsuburaya; J Mizusawa; Y Tanaka; N Fukushima; A Nashimoto; M Sasako
Journal:  Br J Surg       Date:  2014-03-25       Impact factor: 6.939

10.  Preoperative multidetector-row computed tomography scan staging for lymphatic gastric cancer spread.

Authors:  Paolo Morgagni; Enrico Petrella; Barbara Basile; Alberto Mami; Augusto Soro; Andrea Gardini; Filippo Calzolari; Domenico Garcea; Mauro Bertocco
Journal:  World J Surg Oncol       Date:  2012-09-24       Impact factor: 2.754

View more
  2 in total

Review 1.  Value and impact factors of multidetector computed tomography in diagnosis of preoperative lymph node metastasis in gastric cancer: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Mingxu Luo; You Lv; Xiuyu Guo; Hongmei Song; Guoqiang Su; Bo Chen
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

2.  The impact of histological type on the accuracy of preoperative N staging in patients with gastric cancer.

Authors:  Atsushi Yamamoto; Yoshihiko Kawaguchi; Kensuke Shiraishi; Hidenori Akaike; Hiroki Shimizu; Shinji Furuya; Naohiro Hosomura; Hidetake Amemiya; Hiromichi Kawaida; Makoto Sudo; Hiroshi Kono; Daisuke Ichikawa
Journal:  World J Surg Oncol       Date:  2019-08-01       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.